Sunday, October 02, 2022 10:44:05 AM
Todos have been good enough to keep us posted with their plans going forward. Being a relatively new shareholder I think that it's getting a bit confusing with all of the plans the company has versus what has actually already transpired. After a while promised don't make the shareprice stronger since a lot of old news and hopes are already built-in to the shareprice.
I'm getting confused as to what is actually really being done NOW ....we have Tollovid now as a online revenue stream, testing is confusing in that some tests are approved and being used somewhere and clinics are planned , but is testing bringing in revenue now?
And that's another thing. What is actually in clinical testing now as we speak?
Are there other revenue streams that are actually bringing in money Now?
I think most of the action/volume on the shareprice looks like micro penny flippers and HFT's so the shareprice is vulnerable....Press Releases with future plans no longer move it or strengthen it.
I have read the news but still confused.
So the question is are there other or any revenue streams besides Tollovid?
And are we currently actively in a clinical trial?
Recent TOMDF News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/17/2023 12:29:32 PM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM